ACA
RVMD icon

Avoro Capital Advisors’s Revolution Medicines RVMD Stock Holding History

Avoro Capital Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$430M Sell
2,297,000
-47,444
-2% -$6.93M 3.86% 8
2026
Q1 		$228M Buy
2,344,444
+174,444
+8% +$17.6M 2.24% 15
2025
Q4 		$173M Buy
+2,170,000
New +$142M 1.7% 17
2020
Q3 		– Sell
-304,000
Closed -$9.6M – 52
2020
Q2 		$9.6M Sell
304,000
-146,000
-32% -$4.59M 0.19% 41
2020
Q1 		$9.86M Buy
+450,000
New +$12.5M 0.33% 33

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Avoro Capital Advisors's RVMD Position: Q2 2026 in Review

Avoro Capital Advisors reduced its Revolution Medicines (RVMD) stake by 2% in Q2 2026, selling an estimated $6.93M and leaving 2,297,000 shares worth $430M. The position accounts for 3.86% of the portfolio, ranked #8.

Avoro Capital Advisors first reported a position in RVMD in Q1 2020 and has held it in 5 quarters since. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Avoro Capital Advisors held 2,297,000 shares of Revolution Medicines worth $430M as of Q2 2026.
  • Avoro Capital Advisors sold 47,444 Revolution Medicines shares in Q2 2026, an estimated $6.93M.
  • Revolution Medicines made up 3.86% of Avoro Capital Advisors's portfolio in Q2 2026, its #8 holding.
  • Avoro Capital Advisors first reported a position in Revolution Medicines in Q1 2020 and has held it in 5 quarters since.
  • 688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Avoro Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.